OpGen
Roche, Thermo Fisher Scientific, DiaSorin, BioMérieux, and Others Obtain FDA Clearances in September
Roche obtained clearance for a modification, which decreases inference to biotin, to its cleared Elecsys Troponin T Gen 5 immunoassay for myocardial infarction.
OpGen Receives FDA Clearance for AMR Panel, Prelim Q3 Revenues Up 9 Percent
The firm's Acuitas AMR Gene Panel tests for 28 genetic AMR markers in isolated bacterial colonies from 26 different pathogens.
OpGen Q2 Revenues Fall 32 Percent
The decline was driven by the dissolution of the firm's FISH business and the completion of an R&D project at subsidiary Ares Genetics.
In Brief This Week: OpGen, Yale School of Public Health, ProPhase Labs, Core Diagnostics, and More
News items for the in vitro diagnostics industry for the week of June 7, 2021.
OpGen Q1 Revenues Rise 34 Percent on Combination With Curetis
OpGen said it is awaiting a clearance decision for its Unyvero pneumonia cartridge in China, where it is currently under review and pending approval.
Mar 25, 2021
OpGen Fourth Quarter Revenues Increase 64 Percent
Feb 9, 2021
OpGen Enters $25M Direct Offering Agreement
Jan 13, 2021
OpGen Preliminary Q4 Revenue Climbs 63 Percent
Nov 24, 2020
OpGen Inks $10M Private Placement Agreement
Aug 20, 2020
OpGen Nabs CE-IVD Mark for SARS-CoV-2 Kit
Aug 12, 2020
OpGen Q2 Revenues Climb 20 Percent
Jul 15, 2020